IN THE NEWS
CARTANA launches expanded range of In Situ Sequencing kits for high throughput single cell gene expression mapping
14 May 2020
CARTANA launches expanded range of In Situ Sequencing (ISS) kits designed to increase the efficiency and enable ISS on virtually any tissue sample.
NEXT GENERATION ISS PRODUCTS: High Sensitivity Library Preparation Kit and In Situ Sequencing Kit
1 May 2020
CARTANA launches expanded range of In Situ Sequencing kits for high throughput single cell gene expression mapping. Universal capability for all organs and species on fresh/fixed frozen & FFPE samples
IN THE NEWS
New Products Posted to GenomeWeb: Horizon Discovery, Cartana, ProteoGenix, More
1 May 2020
News on CARTANA new products have gotten out! CARTANA new products are being featured on genomeweb!
IN THE NEWS
Biocompare: Probing the Tumor Microenvironment
28 April 2020
How is cancer influenced by its environment, and, just as importantly, how does cancer affect the Tumor microenvironment? CARTANA’s platform, which works on both FFPE and frozen tissue samples can provide the answers to these questions.
IN THE NEWS
Nordic Life Science News: CARTANA’s In Situ Sequencing chosen as key enabling technology in European Horizon 2020 funded projects
29 January 2020
CARTANA has been featured on the Nordic Life Science News and was recognized as the key enabling technology in European Horizon 2020 funded projects. We are delighted to be the partner for half of the European funded HCA projects!
Podcast at King’s College London
16 October 2019
King’s College London has recently released a podcast with CARTANA. In this podcast, Ph.D. student Dr. Xinyi (Beibei) Du discussed about Single-cell and Spatial Transcriptomics with our CEO and Co-founder, Dr. Malte Kühnemund.
Application Note: Mapping brain cell types with CARTANA In Situ Sequencing on the Nikon Ti2-E microscope
3 October 2019
CARTANA has recently published an application note “Mapping brain cell types with CARTANA In Situ Sequencing (ISS) on the Nikon Ti2-E microscope” in Nature Methods, October 2019. In this application, we show in details how CARTANA ISS is used for mapping transcriptional cell types within the spatial context of mouse brain sections and we thought this can benefit your research.
SME Instrument Phase I
4 September 2019
CARTANA was awarded SME Instrument Phase I from Vinnova. The funding will be used for the improvement of the Library Preparation Kit and to adapt it to be used in the application of oncology, especially immuno-oncology, as well as other areas.
“Spatial and temporal transcriptomics reveal microglia-astroglia crosstalk in the amyloid-β plaque cell niche of Alzheimer’s disease”
12 August 2019
Chen W.T., and Craessaerts, K. et al. (BioRxiv, 2019)
In a recent study by Chen et al. on the effect of the amyloid-β plaque formation on Alzheimer’s disease progress, the use of CARTANA’s ISS technology plays a crucial role by providing insight at the single-cell level and making possible to describe induced transcriptional responses of different brain cells with spatial context. For the first time, a more conclusive evidence on the roles of amyloid plaques in the neurodegenerative process was drawn.
“Spatio-Temporal Structure of Cell Fate Decisions in Murine Neural Crest”
1 July 2019
Soldatov R, Kaucka M. and Kastriti M.E ( Science, 2019)
In this study of the cell fate decision progress of neural crest cells, In Situ Sequencing by Cartana proved to be a crucial complement to the standard methods of single cell sequencing. For the first time, the molecular logic of cell fate decision involved in these rapidly changing cells was revealed- by the dimensions of time and space.
CARTANA, Lunaphore and Stockholm University have started a collaboration on automated Next Generation In Situ Sequencing
10 June 2019
The collaboration aims at the integration and automation of CARTANA’s Next Generation In Situ Sequencing (NGISS) on Lunaphore’s microfluidic tissue processor technology that will greatly simplify In Situ Sequencing workflows in laboratories.
Innovative Start up Phase II Grant
8 October 2018
CARTANA was awarded Innovative Start up Phase II from Vinnova. The funding will be used for the development of the next generation of In Situ Sequencing.
“A spatial atlas of inhibitory cell types in mouse hippocampus”
1 October 2018
Xiaoyan Qian et al., bioRxiv 431957 (October 1) 2018; doi: https://doi.org/10.1101/431957
The latest publication from the Nilsson lab at Scilifelab and Harris lab at UCL in Biorxiv.
They built a spatial atlas of hippocampal CA1 cell types by In Situ sequencing 99 genes in mouse brain sections and demonstrate a probabilistic cell typing method that converts In Situ sequencing data into spatial cell type maps.
CARTANA NEURO KIT
01 June 2018
CARTANA is proud to launch its first product, the NeuroKit. CARTANA’s NeuroKit is an optimized reagent kit that enables the mapping of hundreds of genes and cell types via In Situ Sequencing (ISS) in a single tissue section with high throughput and high sensitivity.